0169-1913 : Zegalogue .6 mg/.6ml Subcutaneous Injection, Solution


NDC0169-1913
Labeler: Novo Nordisk
Product Type: Human Prescription Drug
Drug Name:  Zegalogue
Dosage Form: Subcutaneous Injection, Solution
Application #: NDA214231
Rev. Date: 


NDC Package Codes:

  • 0169-1913-01: 1 CONTAINER IN 1 PACKAGE (0169‑1913‑01) / 1 SYRINGE, GLASS IN 1 CONTAINER / .6 ML IN 1 SYRINGE, GLASS
  • 0169-1913-02: 2 PACKAGE IN 1 CARTON (0169‑1913‑02) / 1 CONTAINER IN 1 PACKAGE (0169‑1913‑12) / 1 SYRINGE, GLASS IN 1 CONTAINER / .6 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Dasiglucagon

Dosage Strength:

  • .6 mg/.6mL

Pharmaceutical Classes:

  • Antihypoglycemic Agent [EPC]
  • Glucagon Receptor Agonists [MoA]
  • Increased Glycogenolysis [PE]

Related Products:

Based on records with the same trade name.
  • 0169-1912 Zegalogue .6 mg/.6ml Subcutaneous Injection, Solution by Novo Nordisk
  • 80644-0012 Zegalogue .6 mg/.6ml Subcutaneous Injection, Solution by Zealand Pharma Us, Inc
  • 80644-0013 Zegalogue .6 mg/.6ml Subcutaneous Injection, Solution by Zealand Pharma Us, Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0169-1913 QR Code

< Prev: 0169-1912Next: 0169-2001 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.